Thrombophilia Testing in Venous Thromboembolism.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40500088.
- Also identified by DOI 10.1016/j.mcna.2025.01.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hereditary thrombophilias, comprising factor V Leiden mutation, prothrombin G20210A mutation, protein C, S, and antithrombin deficiency, and acquired antiphospholipid antibody syndrome, predispose venous thromboembolism (VTE) in various mechanisms. Not only the thrombophilia testing and result interpretation requires special laboratory and expertise but also the indications for thrombophilia testing are variable across centers. This is because the role of thrombophilia in VTE management is still under investigation. This narrative review describes the main thrombophilias to be tested, summarizes the indications for thrombophilia testing, and reports the current evidence regarding their role in the duration and choice of anticoagulation in VTE.
Medical subject headings
- Venous Thromboembolism
- Thrombophilia